150:
127:
192:, is a Chilean pharmaceutical company engaged in the development, production, and sale of pharmaceutical drugs in 15 Latin American countries such as Argentina, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Paraguay, Peru, Venezuela and others and in Vietnam in Asia. The company is one of the largest Pharmaceutical companies in Latin America.
209:
The company’s
Gynopharm division provides a range of therapeutic options, such as oral contraceptives, hormone replacement therapies, antiandrogens, antioxidants, antifungals, and vitamins for women. Its Drugtech division offers antiepileptics, antidepressants, antipsychotics, and antihypertensives
218:
The company’s
Complex Injectable division develops injectable products for the infectious diseases, anesthesia, cardiology, and critical care areas. Its Biomedical Sciences division offers products in various therapeutic areas, such as oncology, organ transplant, dialysis, cancer, diabetes, and
200:
Its
Recalcine division offers products in various therapeutic areas, including general medicine, pediatrics, gastroenterology, traumatology, otorhinolaryngology, ENT, obesity, infectious diseases, and nutrition for the treatment of acute and acute-chronic symptoms. This segment serves general
227:
The company’s K2 division provides self-medicated and personal care products. Its
Mediderm division offers dermatology-related treatment products comprising anti-acne products, topical antibiotic therapy, topical corticoid therapy, oral herpes medication, topical immunomodulator medication,
334:
314:
201:
practitioners, surgeons, pediatricians, gastroenterologists, orthopedic surgeons, rheumatologists, otorhinolaryngologists, pulmonary physicians, obesity specialists, and dieticians.
319:
324:
309:
272:
259:
288:
329:
39:
286:
Staff (15 June 2014). "Abbott Grows
Branded Generics with $ 3.3B CFR Acquiaition". News | Industry Watch.
153:
130:
237:
189:
25:
210:
for the treatment of diseases in the areas of cardiology, neurology, psychiatry, and urology.
53:
43:
303:
33:
142:
94:
72:
236:
On 16 May 2014 it was announced that the company would be acquired by
115:
78:
103:
177:
273:"Abbott Agrees to Purchase Chile's CFR Pharmaceuticals"
271:
Cortez, Michelle Fay; Thomson, Eduardo (16 May 2014).
173:
163:
140:
121:
111:
85:
67:
59:
49:
31:
21:
255:
253:
335:Companies listed on the Santiago Stock Exchange
315:Companies based in Santiago Metropolitan Region
292:(Paper). Vol. 34, no. 12. p. 8.
8:
320:Pharmaceutical companies established in 1922
289:Genetic Engineering & Biotechnology News
16:
15:
260:CFR Financial Statements - Businessweek
249:
325:Chilean companies established in 1922
228:antifungals, and hair loss products.
7:
14:
310:Pharmaceutical companies of Chile
149:
148:
126:
125:
91:Alejandro Weinstein Crenovich,
1:
100:Alejandro Weinstein Manieu,
214:Complex Injectable division
351:
17:CFR Pharmaceuticals S.A
275:. Bloomberg Business.
219:autoimmune diseases.
240:for $ 2.9 billion.
238:Abbott Laboratories
232:Abbott Laboratories
190:Abbott Laboratories
186:CFR Pharmaceuticals
178:CFR Pharmaceuticals
165:Number of employees
18:
205:Gynopharm division
196:Recalcine division
183:
182:
159:
136:
107:
98:
342:
294:
293:
283:
277:
276:
268:
262:
257:
157:
152:
151:
134:
129:
128:
101:
92:
26:Sociedad Anónima
19:
350:
349:
345:
344:
343:
341:
340:
339:
300:
299:
298:
297:
285:
284:
280:
270:
269:
265:
258:
251:
246:
234:
225:
216:
207:
198:
188:, now owned by
166:
145:
99:
88:
81:
75:
54:Pharmaceuticals
36:
12:
11:
5:
348:
346:
338:
337:
332:
330:Chilean brands
327:
322:
317:
312:
302:
301:
296:
295:
278:
263:
248:
247:
245:
242:
233:
230:
224:
221:
215:
212:
206:
203:
197:
194:
181:
180:
175:
171:
170:
167:
164:
161:
160:
146:
141:
138:
137:
133:570.8 million
123:
119:
118:
113:
109:
108:
89:
86:
83:
82:
77:
71:
69:
65:
64:
61:
57:
56:
51:
47:
46:
37:
32:
29:
28:
23:
13:
10:
9:
6:
4:
3:
2:
347:
336:
333:
331:
328:
326:
323:
321:
318:
316:
313:
311:
308:
307:
305:
291:
290:
282:
279:
274:
267:
264:
261:
256:
254:
250:
243:
241:
239:
231:
229:
222:
220:
213:
211:
204:
202:
195:
193:
191:
187:
179:
176:
172:
168:
162:
156:79.6 million
155:
147:
144:
139:
132:
124:
120:
117:
114:
110:
105:
96:
90:
84:
80:
74:
70:
66:
62:
58:
55:
52:
48:
45:
41:
38:
35:
30:
27:
24:
20:
287:
281:
266:
235:
226:
217:
208:
199:
185:
184:
68:Headquarters
22:Company type
223:K2 division
304:Categories
244:References
143:Net income
87:Key people
34:Traded as
112:Products
95:Chairman
73:Santiago
50:Industry
174:Website
122:Revenue
60:Founded
158:(2012)
135:(2012)
169:4,559
116:drugs
79:Chile
154:US$
131:US$
63:1922
104:CEO
44:CFR
40:BCS
306::
252:^
76:,
42::
106:)
102:(
97:)
93:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.